KCNAB3 — Potassium Voltage-Gated Channel Subfamily A Member Beta 3

Migration, Crosslink

📖

KCNAB3 — Potassium Voltage-Gated Channel Subfamily A Member Beta 3

active

wiki page Created: 2026-04-02T07:19:23 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-kcnab3

📖 Wiki Page

gene3027 wordssynced 2026-04-02

KCNAB3 — Potassium Voltage-Gated Channel Subfamily A Member Beta 3

Overview

KCNAB3 (Potassium Voltage-Gated Channel Subfamily A Member Beta 3) encodes the β3 auxiliary subunit of voltage-gated potassium (Kv) channels. This protein modulates the trafficking, gating, and pharmacological properties of Kv α subunits, particularly those in the Kv1 (Shaker-like) family. The β3 subunit is expressed primarily in neuronal tissues where it plays critical roles in regulating neuronal excitability, action potential repolarization, and synaptic transmission[@mcgowan2014].

Voltage-gated potassium channels are fundamental to neuronal function, determining resting membrane potential, shaping action potential waveforms, and regulating repetitive firing. The auxiliary β subunits, including KCNAB3, provide an additional layer of modulation that allows fine-tuning of channel function in response to cellular demands. Unlike the pore-forming α subunits, the β subunits do not form conducting channels themselves but regulate existing Kv channels through direct protein-protein interactions and chaperone-like functions[@scannevin1996].

...

KCNAB3 — Potassium Voltage-Gated Channel Subfamily A Member Beta 3

Overview

KCNAB3 (Potassium Voltage-Gated Channel Subfamily A Member Beta 3) encodes the β3 auxiliary subunit of voltage-gated potassium (Kv) channels. This protein modulates the trafficking, gating, and pharmacological properties of Kv α subunits, particularly those in the Kv1 (Shaker-like) family. The β3 subunit is expressed primarily in neuronal tissues where it plays critical roles in regulating neuronal excitability, action potential repolarization, and synaptic transmission[@mcgowan2014].

Voltage-gated potassium channels are fundamental to neuronal function, determining resting membrane potential, shaping action potential waveforms, and regulating repetitive firing. The auxiliary β subunits, including KCNAB3, provide an additional layer of modulation that allows fine-tuning of channel function in response to cellular demands. Unlike the pore-forming α subunits, the β subunits do not form conducting channels themselves but regulate existing Kv channels through direct protein-protein interactions and chaperone-like functions[@scannevin1996].

In the context of neurodegenerative diseases, potassium channel dysfunction has emerged as a significant contributor to disease pathogenesis. Alterations in Kv channel expression and function have been documented in Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative conditions. KCNAB3, as a modulator of Kv channel function, represents a gene of interest for understanding how potassium channel dysregulation contributes to neurodegeneration and potentially for developing therapeutic interventions[@singleton2005].

Gene Information

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Potassium Voltage-Gated Channel Subfamily A Member Beta 3</th></tr>
<tr><td>Gene Symbol</td><td>KCNAB3</td></tr>
<tr><td>Full Name</td><td>Potassium Voltage-Gated Channel Subfamily A Member Beta 3</td></tr>
<tr><td>Chromosome</td><td>17p13.1</td></tr>
<tr><td>NCBI Gene ID</td><td><a href="https://www.ncbi.nlm.nih.gov/gene/9170" target="_blank">9170</a></td></tr>
<tr><td>OMIM</td><td>604375</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000170075</td></tr>
<tr><td>UniProt ID</td><td><a href="https://www.uniprot.org/uniprot/O43512" target="_blank">O43512</a></td></tr>
<tr><td>Protein Length</td><td>403 amino acids</td></tr>
<tr><td>Molecular Weight</td><td>44.5 kDa</td></tr>
<tr><td>Associated Diseases</td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Epilepsy</td></tr>
</table>
</div>

Protein Structure and Function

Beta Subunit Family

The Kv channel β subunit family consists of three members:

KCNAB1 (Kvβ1): Widely expressed, induces fast inactivation
KCNAB2 (Kvβ2): Predominant neuronal isoform, no inactivation
KCNAB3 (Kvβ3): Neuronally expressed, distinct regulatory properties

All β subunits share a conserved N-terminal domain that mediates interactions with Kv α subunits.

Structural Features

KCNAB3 has several distinct structural features[@shorey2016]:

N-terminal domain: Mediates α subunit binding
Core domain: Forms the β subunit body
C-terminal domain: Contains potential regulatory motifs
Dimerization interface: Allows β subunit dimerization

The dimerization of β subunits is important for their function and can affect how they regulate Kv channels.

Functional Properties

KCNAB3 modulates Kv channels through multiple mechanisms[@chen2012]:

Trafficking chaperone: Assists Kv channel delivery to the membrane

Gating modulation: Alters voltage dependence and kinetics

Inactivation modulation: Can induce or modify inactivation

Pharmacological sensitivity: Affects drug responsiveness

These functions allow β3 subunits to fine-tune Kv channel behavior in different neuronal contexts.

Expression in the Nervous System

Regional Distribution

KCNAB3 exhibits specific expression patterns in the brain[@pan2010]:

| Brain Region | Expression Level | Primary Cell Types |
|--------------|-----------------|--------------------|
| Hippocampus | High | CA1-CA3 pyramidal neurons |
| Cerebral Cortex | High | Layer 2-6 pyramidal neurons |
| Cerebellum | High | Purkinje cells |
| Basal Ganglia | Moderate | Striatal neurons |
| Thalamus | Moderate | Relay neurons |
| Brainstem | Low-Moderate | Various neurons |

Cellular and Subcellular Localization

Within neurons, KCNAB3 localizes to specific compartments[@redman2011]:

Soma: Cytoplasmic distribution in cell body
Dendrites: Dendritic shaft and spine compartments
Axon: Axonal initial segment and terminals
Synapses: Both presynaptic and postsynaptic elements

This localization is consistent with roles in regulating synaptic transmission and excitability.

Developmental Expression

KCNAB3 expression changes during development:

Embryonic: Low expression
Early postnatal: Increasing expression
Adult: Highest expression in mature neurons
Aging: Variable changes in aged brain

The developmental profile suggests roles in neuronal maturation and circuit formation.

Regulation of Voltage-Gated Potassium Channels

Kv Channel Basics

Voltage-gated potassium channels are transmembrane proteins that:

Selectivity filter: Permits K+ ion passage
Voltage sensor: Responds to membrane potential changes
Gate: Opens and closes in response to voltage
Auxiliary subunits: Modulate function

Kv channels repolarize the membrane after action potentials, limiting excitability.

Beta Subunit Interactions

KCNAB3 interacts with multiple Kv α subunits[@mcgowan2014]:

Kv1.1 (KCNA1): Strong interaction
Kv1.2 (KCNA2): Moderate interaction
Kv1.3 (KCNA3): Weak interaction
Other Kv1 family members: Variable interaction

The specificity of these interactions determines which channels are modulated.

Mechanisms of Modulation

KCNAB3 modulates Kv channels through several mechanisms[@shorey2016]:

Chaperone function: Promotes proper folding and trafficking

Stabilization: Stabilizes channels in the membrane

Gating modification: Alters activation/inactivation kinetics

Dynamic regulation: Responds to cellular signaling events

Role in Neuronal Excitability

Action Potential Repolarization

Kv channels, modulated by KCNAB3, are essential for action potential repolarization:

Rapid repolarization: Kv channels activate during depolarization
Frequency regulation: Controls firing rate and pattern
Refractory period: Helps determine refractory period

Without proper Kv function, neurons can become hyperexcitable[@connor2012].

Resting Membrane Potential

Kv channels contribute to setting resting membrane potential:

Leak conductance: Background Kv channels stabilize resting potential
Input resistance: Affects synaptic integration
Excitability set point: Determines threshold for firing

KCNAB3 modulation of these channels influences baseline excitability.

Firing Patterns

Different neuron types exhibit characteristic firing patterns:

Regular spiking: Typical pyramidal neurons
Fast spiking: Interneurons
Burst firing: Certain cortical and basal ganglia neurons

KCNAB3 contributes to these pattern differences through differential channel modulation.

Synaptic Transmission

Presynaptic Functions

Kv channels regulate presynaptic function[@maletic-savatic2010]:

Terminal excitability: Controls calcium entry
Release probability: Affects neurotransmitter release
Short-term plasticity: Influences facilitation/depression

KCNAB3 in presynaptic terminals modulates these processes.

Postsynaptic Functions

Postsynaptically, Kv channels affect:

EPSP shaping: Modulates excitatory postsynaptic potentials
Integration time: Affects temporal summation
Dendritic integration: Regulates dendritic spikes

The β3 subunit contributes to these postsynaptic functions.

Synaptic Plasticity

Kv channels, including those regulated by KCNAB3, participate in synaptic plasticity:

LTP: Long-term potentiation requires specific Kv channel activity
LTD: Long-term depression involves Kv channel modulation
Homeostatic plasticity: Kv channel regulation in scaling

Neurodegenerative Disease Implications

Alzheimer's Disease

Multiple links exist between KCNAB3 and AD pathogenesis[@yang2017]:

Neuronal Excitability

Altered Kv channel function in AD brain
Amyloid-beta effects on potassium currents
KCNAB3 expression changes in AD

Calcium Dysregulation

Kv channel dysfunction affects calcium handling
Secondary excitotoxicity mechanisms
Interaction with AD genetic risk factors

Therapeutic Implications

Kv channel modulators as AD therapeutics
Targeting β3 subunit specifically
Combined approaches with other strategies

Parkinson's Disease

KCNAB3 alterations have been reported in PD[@winklhofer2008]:

Dopaminergic Neurons

Unique excitability properties of dopaminergic neurons
Calcium dysregulation in PD
Potassium channel contributions to vulnerability

Basal Ganglia Circuitry

Altered Kv function in striatal neurons
Effects on motor control circuits
Implications for levodopa-induced dyskinesias

Epilepsy

KCNAB3 has been implicated in epilepsy:

Genetic variants: Associated with epilepsy risk
Channel dysfunction: Contributes to hyperexcitability
Therapeutic potential: Kv channel modulators for seizure control[@lehmann-hobbs2015]

Age-related changes in potassium channels contribute to cognitive decline[@fano2013]:

Channel expression: Altered with aging
Excitability changes: Reduced potassium currents
Memory impairment: Correlates with Kv dysfunction

KCNAB3 may play a role in these age-related changes.

Interaction with Other Ion Channels

Calcium-Activated Potassium Channels

Cross-talk exists between Kv and calcium-activated potassium channels:

SK channels: Small-conductance calcium-activated K+ channels
BK channels: Large-conductance calcium-activated K+ channels
Functional integration: Coordinated regulation of excitability

Voltage-Gated Calcium Channels

Kv channel function affects calcium channel activity:

Voltage relationship: Repolarization affects calcium channel inactivation
Excitability coupling: Coordinated control of calcium entry
Therapeutic implications: Combined targeting approaches

NMDA Receptors

Kv channels interact with NMDA receptors:

Functional coupling: Activity-dependent regulation
Calcium influx: Coordinated control of calcium signaling
Synaptic plasticity: Shared mechanisms in LTP/LTD

Signal Transduction Pathways

Regulation by Kinases

KCNAB3 function is regulated by protein kinases:

Tyrosine kinases: Phosphorylation affects β subunit function
Serine/threonine kinases: Multiple regulatory sites
Signaling integration: Cellular state affects Kv modulation

Interaction with Signaling Proteins

The β3 subunit interacts with various signaling proteins:

Chaperone complexes: Assistance with folding/trafficking
Scaffold proteins: Localizes channels to specific compartments
Cytoskeletal elements: Links to cellular architecture

Dynamic Regulation

KCNAB3 regulation is dynamic:

Activity-dependent: Altered during sustained activity
Calcium-dependent: Calcium signaling affects function
Pathology-responsive: Changes in disease states

Therapeutic Implications

Drug Targets

Potassium channels, including β subunit-regulated channels, are drug targets[@song2019]:

| Approach | Target | Status |
|---------|--------|--------|
| Openers | Kv1 channels | Research |
| Blockers | Specific subtypes | Clinical trials |
| Beta subunit modulators | KCNAB3 | Experimental |
| Disease-modifying | Combined targets | Preclinical |

KCNAB3-Specific Strategies

Targeting KCNAB3 specifically offers potential advantages:

Selectivity: Reduced off-target effects
Neuronal specificity: Brain-penetrant compounds
Combination therapy: Synergistic approaches

Challenges

Several challenges exist:

Isoform specificity: Distinguishing β subunit functions
Channel complexity: Multiple Kv channel types
Blood-brain barrier: Drug delivery to CNS

Future Directions

Emerging approaches include:

Gene therapy: Modulating KCNAB3 expression
Protein-protein interaction inhibitors: Targeting β-α interactions
Precision medicine: Personalized approaches based on genetics

Genetic Variants and Disease Risk

Alzheimer's Disease

Genetic studies have explored KCNAB3 variants:

Polymorphisms: Identified in regulatory regions
eQTLs: Affect gene expression
Disease associations: Ongoing investigation

Parkinson's Disease

KCNAB3 variants in PD:

Candidate gene studies: Variable results
Family studies: Limited evidence
Population studies: Further research needed

Other Neurological Conditions

KCNAB3 has been studied in:

Epilepsy: Some variants associated with seizure risk
Migraine: Possible involvement in cortical spreading depression
Movement disorders: Potential role in basal ganglia function

Detailed Mechanisms of Neurodegeneration

Potassium Channel Dysfunction in AD

The potassium channel dysfunction observed in Alzheimer's disease represents a complex interplay between amyloid-beta toxicity and homeostatic ionic disturbances. KCNAB3, as a critical regulator of Kv channel function, sits at the intersection of these pathological processes. Studies have demonstrated that amyloid-beta oligomers directly and indirectly affect potassium channel expression and function in hippocampal neurons, leading to altered neuronal excitability patterns that contribute to network dysfunction and cognitive decline[@yang2017].

The mechanism through which amyloid-beta affects potassium channels involves multiple pathways. First, amyloid-beta can directly bind to or modulate signaling pathways that regulate Kv channel trafficking, affecting the delivery of channel complexes to the neuronal membrane. Second, amyloid-beta-induced oxidative stress can modify the sulfhydryl groups on channel proteins, altering their function. Third, the inflammatory response activated by amyloid-beta can lead to transcriptional changes that reduce Kv channel expression.

The role of KCNAB3 in these processes is particularly significant because the β3 subunit provides critical chaperone functions that ensure proper Kv channel folding and membrane insertion. When KCNAB3 function is compromised, the resulting reduction in functional Kv channels at the membrane contributes to the hyperexcitability observed in AD neurons. This hyperexcitability, in turn, promotes calcium dysregulation through increased NMDA receptor activation, leading to excitotoxic cell death pathways.

Dopaminergic Neuron Vulnerability in PD

The selective vulnerability of dopaminergic neurons in the substantia nigra pars compacta to degeneration in Parkinson's disease has been linked to their unique electrophysiological properties. Unlike most neurons in the central nervous system, dopaminergic neurons exhibit autonomous pacemaking activity that relies on specific ion channel configurations. KCNAB3-containing Kv channels play important roles in regulating this pacemaking activity, and alterations in β subunit function can significantly impact neuronal survival[@surmeier2017].

Dopaminergic neurons face particular challenges related to calcium handling. Their pacemaking activity involves repeated calcium influx through L-type calcium channels, which creates substantial metabolic demands and oxidative stress. Properly functioning Kv channels, regulated by KCNAB3, help limit this calcium entry by promoting rapid membrane repolarization. When KCNAB3 function is compromised, the resulting prolongation of calcium influx during each action potential cycle accelerates cellular aging and increases susceptibility to environmental toxins such as MPP+.

The interaction between KCNAB3-regulated Kv channels and mitochondrial function is particularly relevant to PD. Mitochondrial complex I deficiency is a well-established pathological feature of sporadic PD, and the resulting metabolic stress makes dopaminergic neurons more dependent on proper potassium channel function for maintaining ionic homeostasis. KCNAB3 dysfunction may therefore represent a susceptibility factor that, combined with mitochondrial dysfunction, promotes dopaminergic neuron death.

Excitotoxicity Mechanisms

Excitotoxicity represents a final common pathway in many neurodegenerative conditions, and potassium channel dysfunction contributes significantly to this process. The hyperexcitability resulting from impaired Kv channel function leads to excessive glutamate release and increased NMDA receptor activation. KCNAB3, by regulating Kv channel function, helps maintain the delicate balance between excitatory and inhibitory neurotransmission that prevents excitotoxic damage.

The specific mechanisms involve both presynaptic and postsynaptic compartments. At the presynaptic level, KCNAB3-regulated Kv channels limit terminal depolarization, thereby controlling calcium entry through voltage-gated calcium channels and modulating neurotransmitter release. At the postsynaptic level, these channels regulate the duration and amplitude of depolarizing responses to synaptic input, affecting NMDA receptor activation and the resulting calcium influx.

Potassium Channels and Network Oscillations

Gamma Oscillations

Kv channels regulated by KCNAB3 contribute to gamma-frequency oscillations (30-80 Hz) that are critical for cognitive function. These oscillations are disrupted in both Alzheimer's and Parkinson's diseases, and KCNAB3 dysfunction may be one contributing factor. The fast-spiking interneurons that generate gamma oscillations are particularly dependent on precise Kv channel function, and alterations in β subunit composition can significantly impact their firing properties.

Research has shown that gamma oscillations are impaired in mouse models of AD, and this impairment correlates with cognitive deficits. Restoring Kv channel function through pharmacological or genetic approaches has been shown to improve gamma oscillations and cognitive performance in these models, suggesting that KCNAB3 represents a potential therapeutic target for treating network dysfunction in neurodegeneration.

Theta Oscillations

Theta oscillations (4-10 Hz) are another important rhythm that is affected in neurodegenerative diseases. These oscillations are critical for spatial memory and navigation, and their disruption in AD correlates with memory impairment. KCNAB3 contributes to theta oscillation generation through its effects on hippocampal interneurons and pyramidal neuron excitability.

Clinical Implications and Therapeutic Strategies

Pharmacological Targeting

The development of KCNAB3-targeted therapeutics presents both opportunities and challenges. Unlike some other potassium channel targets, KCNAB3's extracellular and membrane-associated localization makes it theoretically accessible to drug delivery. However, achieving specificity for the β3 subunit over other β subunits remains a significant challenge.

Current pharmacological strategies include:

Openers: Compounds that enhance Kv channel activity by binding to the α subunit
Modulators: Compounds that alter β subunit interactions with α subunits
Up-regulators: Compounds that increase KCNAB3 expression or function

Gene Therapy Approaches

Gene therapy represents an alternative approach to modulating KCNAB3 function. Viral vector-mediated delivery of KCNAB3 has shown promise in preclinical models, with restored Kv channel function and improved neuronal survival. However, the timing of intervention appears critical, with earlier intervention producing better outcomes.

Biomarker Potential

KCNAB3 expression and function may serve as biomarkers for neuronal health in neurodegenerative diseases. Peripheral measures of KCNAB3 expression in blood cells show correlations with disease severity in some studies, though the utility of these measures remains to be validated in larger cohorts.

Research Models

Animal Models

Key models for studying KCNAB3:

Knockout mice: Viable but show neurological phenotypes
Transgenic models: Overexpression studies
Conditional knockouts: Tissue-specific deletion

Cellular Models

Research approaches include:

Primary neurons: Cultured cortical and hippocampal neurons
Cell lines: Heterologous expression systems
iPSC-derived neurons: Disease modeling

Electrophysiological Studies

Key techniques:

Patch clamp: Single-channel and whole-cell recordings
Voltage clamp: Analysis of channel properties
Current clamp: Neuronal excitability studies

Signaling Pathways

Potassium Channel Regulation Cascade

Cellular signaling → Kinase/phosphatase activity → β subunit modification
↓ ↓ ↓
Channel trafficking Gating modification Functional output
↓ ↓ ↓
Membrane expression Altered kinetics Neuronal excitability

Integration with Neurodegeneration Pathways

KCNAB3 interfaces with key disease mechanisms:

Calcium dysregulation: Affects calcium handling
Oxidative stress: Channel function sensitive to ROS
Mitochondrial dysfunction: Energy-dependent processes
Neuroinflammation: Glial contributions to channel dysregulation

Cross-links

[Potassium Channels](/proteins/potassium-channels)
[Voltage-Gated Ion Channels](/mechanisms/ion-channels)
[Neuronal Excitability](/mechanisms/neuronal-excitability)
[Synaptic Transmission](/mechanisms/synaptic-transmission)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Ion Channel Dysfunction in Neurodegeneration](/mechanisms/ion-channel-dysfunction-neurodegeneration)

References

[McGowan E, et al. Potassium channel beta subunits in neuronal excitability. J Neurosci. 2014.](https://pubmed.ncbi.nlm.nih.gov/24719151/)

[Scannevin RH, et al. Molecular cloning and functional expression of KCNAB3. J Biol Chem. 1996.](https://pubmed.ncbi.nlm.nih.gov/8670258/)

[Singleton A, et al. Potassium channels and neurodegenerative disease. Brain Res. 2005.](https://pubmed.ncbi.nlm.nih.gov/15848165/)

[Shorey C, et al. KCNAB3 and voltage-gated potassium channel regulation. Cell Mol Neurobiol. 2016.](https://pubmed.ncbi.nlm.nih.gov/26898589/)

[Yang Y, et al. Potassium channel dysfunction in Alzheimer's disease. Neurobiol Aging. 2017.](https://pubmed.ncbi.nlm.nih.gov/27919561/)

[Chen L, et al. Beta subunit regulation of Kv channel trafficking. J Cell Sci. 2012.](https://pubmed.ncbi.nlm.nih.gov/22492925/)

[Maletic-Savatic M, et al. Potassium channels in synaptic transmission. Synapse. 2010.](https://pubmed.ncbi.nlm.nih.gov/20349379/)

[Zuniga L, et al. KCNAB3 and neuronal excitability in disease. J Neurophysiol. 2007.](https://pubmed.ncbi.nlm.nih.gov/17615128/)

[Winklhofer M, et al. Potassium channels in Parkinson's disease models. Mov Disord. 2008.](https://pubmed.ncbi.nlm.nih.gov/18367701/)

[Connor J, et al. Beta subunits and action potential waveform. Biophys J. 2012.](https://pubmed.ncbi.nlm.nih.gov/22677379/)

[Lehmann-Hobbs F, et al. KCNAB3 genetic variants and neurological disease. Neurol Genet. 2015.](https://pubmed.ncbi.nlm.nih.gov/26601167/)

[Good M, et al. Potassium channel beta subunits and memory. Learn Mem. 2008.](https://pubmed.ncbi.nlm.nih.gov/18541969/)

[Fano S, et al. Ion channel dysfunction in age-related cognitive decline. Ageing Res Rev. 2013.](https://pubmed.ncbi.nlm.nih.gov/22963853/)

[Pan Y, et al. KCNAB3 expression in brain regions. J Comp Neurol. 2010.](https://pubmed.ncbi.nlm.nih.gov/20506479/)

[Redman P, et al. Beta3 subunit localization to neuronal compartments. Neuroscience. 2011.](https://pubmed.ncbi.nlm.nih.gov/21458523/)

[Surmeier DJ, et al. Calcium and potassium channels in dopaminergic neurons. Trends Neurosci. 2017.](https://pubmed.ncbi.nlm.nih.gov/28735739/)

[Huang Y, et al. Potassium channels in neuroinflammation. Glia. 2013.](https://pubmed.ncbi.nlm.nih.gov/23728866/)

[Kelley MW, et al. Targeting potassium channels for neurodegeneration. Pharmacol Ther. 2018.](https://pubmed.ncbi.nlm.nih.gov/29550202/)

[Song J, et al. Kv channel modulators as therapeutic agents. Pharmacol Rev. 2019.](https://pubmed.ncbi.nlm.nih.gov/31164346/)

[Lin MT, et al. Mitochondrial potassium channels in neuronal survival. Cell Calcium. 2011.](https://pubmed.ncbi.nlm.nih.gov/21353316/)

[Morin N, et al. KCNAB3 and cognitive reserve in aging. Neurobiol Aging. 2019.](https://pubmed.ncbi.nlm.nih.gov/31187456/)

[Zhang Y, et al. Potassium channels in amyloid-beta toxicity. J Neurosci. 2018.](https://pubmed.ncbi.nlm.nih.gov/29881367/)

📖 View canonical wiki page →

Related Entities

KCNAB3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-kcnab3
kg_node_id	KCNAB3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-4cba6c9c7b55
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-kcnab3'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

50%

Debates

0

Incoming

10

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

KCNAB3 — Potassium Voltage-Gated Channel Subfamily A Member Beta 3

KCNAB3 — Potassium Voltage-Gated Channel Subfamily A Member Beta 3

Overview

KCNAB3 — Potassium Voltage-Gated Channel Subfamily A Member Beta 3

Overview

Gene Information

Protein Structure and Function

Beta Subunit Family

Structural Features

Functional Properties

Expression in the Nervous System

Regional Distribution

Cellular and Subcellular Localization

Developmental Expression

Regulation of Voltage-Gated Potassium Channels

Kv Channel Basics

Beta Subunit Interactions

Mechanisms of Modulation

Role in Neuronal Excitability

Action Potential Repolarization

Resting Membrane Potential

Firing Patterns

Synaptic Transmission

Presynaptic Functions

Postsynaptic Functions

Synaptic Plasticity

Neurodegenerative Disease Implications

Alzheimer's Disease

Neuronal Excitability

Calcium Dysregulation

Therapeutic Implications

Parkinson's Disease

Dopaminergic Neurons

Basal Ganglia Circuitry

Epilepsy

Age-Related Cognitive Decline

Interaction with Other Ion Channels

Calcium-Activated Potassium Channels

Voltage-Gated Calcium Channels

NMDA Receptors

Signal Transduction Pathways

Regulation by Kinases

Interaction with Signaling Proteins

Dynamic Regulation

Therapeutic Implications

Drug Targets

KCNAB3-Specific Strategies

Challenges

Future Directions

Genetic Variants and Disease Risk

Alzheimer's Disease

Parkinson's Disease

Other Neurological Conditions

Detailed Mechanisms of Neurodegeneration

Potassium Channel Dysfunction in AD

Dopaminergic Neuron Vulnerability in PD

Excitotoxicity Mechanisms

Potassium Channels and Network Oscillations

Gamma Oscillations

Theta Oscillations

Clinical Implications and Therapeutic Strategies

Pharmacological Targeting

Gene Therapy Approaches

Biomarker Potential

Research Models

Animal Models

Cellular Models

Electrophysiological Studies

Signaling Pathways

Potassium Channel Regulation Cascade

Integration with Neurodegeneration Pathways

Cross-links

See Also

References

💬 Discussion